Cite
HARVARD Citation
Harnden, A. et al. (n.d.). Improved binding affinity and pharmacokinetics enables sustained degradation of BCL6 in vivo. European journal of cancer. pp. S104-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Harnden, A. et al. (n.d.). Improved binding affinity and pharmacokinetics enables sustained degradation of BCL6 in vivo. European journal of cancer. pp. S104-. [Online].